Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC.
Kinehara Y, Shiroyama T, Tamiya A, Tamiya M, Minami S, Kanazu M, Morimura O, Niki T, Tetsumoto S, Taniguchi Y, Kuge T, Nishino K, Nagatomo I, Kumanogoh A, Tachibana I.
Kinehara Y, et al. Among authors: niki t.
JTO Clin Res Rep. 2023 Oct 12;4(11):100586. doi: 10.1016/j.jtocrr.2023.100586. eCollection 2023 Nov.
JTO Clin Res Rep. 2023.
PMID: 38029024
Free PMC article.